To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 20,922 shares, the number of shares held decreased 1.27% compared to the previous period and now represents 2% of the total position.
      49Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veeva by 528 shares, the number of shares held decreased 1.25% compared to the previous period and now represents 0.6% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 29,568 shares, the number of shares held decreased 1.27% compared to the previous period and now represents 5.03% of the total position.
      206Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 146,399 shares, the number of shares held decreased 1.27% compared to the previous period and now represents 1.47% of the total position.
      4.91K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 583 shares, the number of shares held decreased 1.25% compared to the previous period and now represents 1.39% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 3,564 shares, the number of shares held decreased 1.27% compared to the previous period and now represents 2.03% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 27,841 shares, the number of shares held decreased 1.27% compared to the previous period and now represents 2.03% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 7,271 shares, the number of shares held decreased 1.27% compared to the previous period and now represents 4.82% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 5,280 shares, the number of shares held decreased 1.27% compared to the previous period and now represents 2.68% of the total position.
      83Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 43,362 shares, the number of shares held decreased 1.27% compared to the previous period and now represents 1.06% of the total position.
      1Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed